M

Matrixome

2 employees

Matricome develops regenerative medicines by disseminating laminin E8 fragment technology.

Basic info

Industry

biotechnology research

Sectors

Alternative Medicine
Product Research
Nursing and Residential Care
Medical
Health Care

Date founded

2015

Funding rounds raised

Total raised

$2.3M

from 2 investors over 2 rounds

M

Matrixome raised $2.3M on February 1, 2016

Investors: ＳＭＢＣベンチャーキャピタル（株） and Nippi, Inc.

FAQ